IL13 and neoplasm: Altogether, ILC cells including NK cells could contribute to the increased level of TNF-alpha, GM-CSF, IFN-gamma, IL-4, IL-5, IL-13, IL-17, and IL-22, modulating TME and contributing to tumor progression or antitumor activities.